Signal Diagnostic™ is a 7-day AI Position Report™ showing how major AI platforms describe your company, compare you to competitors, and where perception may be costing trust, pipeline, or investor confidence before the first conversation starts.
Your buyers research before they ever reach out. So do investors, analysts, and competitors. Increasingly, that research starts with an AI platform: ChatGPT, Claude, Gemini, or Perplexity, not your website.
Those platforms have already formed an answer to what your company is, what category it belongs in, and who it competes with. That answer is assembled from whatever the public record happens to contain: old press, outdated positioning, a product page that no longer reflects where you are headed, or competitor language that is easier to retrieve.
If your company has repositioned, raised, launched, rebranded, or moved upmarket, AI may still be describing the company you used to be.
You may not see it happening. But the people deciding whether to take the meeting can.
Is AI describing your company accurately, or repeating an older story?
What category do AI platforms place you in, and is it the one you want?
Who does AI compare you to, and is that the comparison set that helps you win?
Where is your current narrative landing, and where is it being flattened?
What proof is missing that buyers and investors need to see?
What should you fix first?
If the company you are becoming is ahead of the company the market still sees, this is for you.
AI perception matters most when your company is in motion.
When the public record lags behind the company you are becoming, AI platforms can keep repeating older language before buyers, investors, or partners ever reach your team.
The Signal Diagnostic gives leadership a clear read on what AI is saying now, and what needs to be corrected first.
Signal Diagnostic is not for companies looking for generic SEO advice, content volume, or a monitoring dashboard.
It is built for leadership teams facing a high-stakes moment where market perception, category clarity, investor confidence, or competitive framing matters.
An executive-grade strategic document, delivered in 7 days.
The single clearest read on where your AI perception stands.
What the major AI platforms agree on about your company.
Where the platforms disagree, and what that reveals.
How you are framed against your comparison set.
Where buyer or investor confidence is most at risk.
Prioritized, specific, actionable recommendations.
If you do only one thing in the next 30 days.
A clear sequence for closing the gap.
Written to be read by a CEO and shared with a board. Not a dashboard. Not a scan. A strategic document.
We built a full sample report for a fictional company so you can see exactly what a Signal Diagnostic looks like before you apply.
View the MeridianOps Sample Report →Illustrative sample. Fictional company, created for demonstration. Real client reports are confidential.
Complete a short application so we can confirm the Diagnostic is likely to produce useful strategic signal for your company.
We review each request to confirm the Diagnostic is likely to produce useful strategic signal. If approved, you'll receive payment and intake next steps. No sales call is required.
You tell us what changed recently and what you want AI, buyers, or investors to understand.
Your AI Position Report arrives within 7 days.
Add a live strategic walkthrough of the findings, priority risks, and recommended next moves.
The report is the product. There is no drawn-out sales process and no obligation beyond the Diagnostic itself.
We are accepting the first 10 approved companies into the Signal Diagnostic founding cohort.
Quick application review. No sales call required.
Founding cohort pricing is temporary and reserved for early approved companies.
Apply for the $4,500 Founding Cohort →Some reports surface a problem worth a dedicated fix: a category that needs rebuilding, a proof architecture that is not landing, or a narrative that breaks at the conversion layer. When that happens, Strake may recommend a scoped Strategic Sprint.
That is the exception, not the default. The Signal Diagnostic stands on its own. The Sprint exists only when the report shows there is something worth fixing.
Every Signal Diagnostic is prepared for private executive use. Reports are never shared, published, or referenced without the explicit approval of the company. The sample on this page is fictional for exactly that reason. Real client work stays confidential.
Thanks for applying for the Signal Diagnostic founding cohort. We review each request to confirm the Diagnostic is likely to produce useful strategic signal. If approved, you'll receive payment and intake next steps. No sales call is required.
Seven days from confirmed intake to delivered report.
Yes. The founding cohort uses a short application review. If approved, you receive payment and intake next steps. No sales call is required.
Signal Diagnostic combines a cross-platform AI intelligence process with senior strategist review. Automated analysis produces the foundation. Human judgment produces the strategic verdict.
No. This is a strategic diagnostic, not a monitoring dashboard. It tells you what AI is saying, why it matters, and what to do. A decision-grade document, not a metrics feed.
A short intake. No long onboarding and no access to internal systems. The analysis works from public signal and your context.
You receive a clear picture and a 90-day roadmap. Some teams act on the recommendations internally. Others add an Executive Readout to align leadership. If the findings reveal a larger positioning, proof, or category opportunity, Strake can scope a Strategic Sprint to help translate the intelligence into action.
We are refining the productized delivery model with a limited group of early companies. Founding pricing reflects that. It is temporary and reserved for the first approved cohort.
We'll tell you honestly, and where we can, point you toward what would help instead.